Cargando…

Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study

Aim: Multivascular disease, indicating concurrent arteriosclerotic lesions in a number of different vascular beds, is an independent risk factor for recurrent ischemic events in the general population. However, the impact of multivascular disease on the risk of developing cardiovascular disease has...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Shigeru, Nakano, Toshiaki, Hiyamuta, Hiroto, Taniguchi, Masatomo, Tokumoto, Masanori, Masutani, Kosuke, Ooboshi, Hiroaki, Tsuruya, Kazuhiko, Kitazono, Takanari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147568/
https://www.ncbi.nlm.nih.gov/pubmed/32684556
http://dx.doi.org/10.5551/jat.54098
_version_ 1783697656905728000
author Tanaka, Shigeru
Nakano, Toshiaki
Hiyamuta, Hiroto
Taniguchi, Masatomo
Tokumoto, Masanori
Masutani, Kosuke
Ooboshi, Hiroaki
Tsuruya, Kazuhiko
Kitazono, Takanari
author_facet Tanaka, Shigeru
Nakano, Toshiaki
Hiyamuta, Hiroto
Taniguchi, Masatomo
Tokumoto, Masanori
Masutani, Kosuke
Ooboshi, Hiroaki
Tsuruya, Kazuhiko
Kitazono, Takanari
author_sort Tanaka, Shigeru
collection PubMed
description Aim: Multivascular disease, indicating concurrent arteriosclerotic lesions in a number of different vascular beds, is an independent risk factor for recurrent ischemic events in the general population. However, the impact of multivascular disease on the risk of developing cardiovascular disease has not been fully evaluated in patients receiving hemodialysis. Methods: A total of 3,504 hemodialysis patients were prospectively followed for 10 years. In this study, multivascular disease was defined as the coexistence of coronary artery disease and stroke. We examined the relationship between multivascular disease and the occurrence of composite cardiovascular endpoint, consisting of cardiovascular death, nonfatal coronary artery disease, nonfatal stroke, and peripheral artery disease. Results: The proportion of participants with multivascular disease was 5.7% (n = 200) at baseline. During follow-up (median, 106.6 months; interquartile range, 50.1–121.8 months), 1,311 patients experienced the composite endpoint, which was defined as at least one of the following: cardiovascular death (n = 620), nonfatal coronary artery disease (n = 318), nonfatal stroke (n = 340), and peripheral artery disease (n = 257). Compared with the group with no history of cardiovascular disease, the risk of experiencing the composite endpoint increased significantly with higher numbers of injured vascular beds in patients with single vascular disease (hazard ratio, 1.68; 95% confidence interval, 1.49–1.89) and in those with multivascular disease (hazard ratio, 2.11; 95% confidence interval, 1.71–2.60). In a multivariable analysis, multivascular disease was an independent predictor of cardiovascular events, in addition to diabetes, aging, and hypertension. Conclusions: This study clearly demonstrated that multivascular disease was a powerful predictor for cardiovascular mortality and morbidity in patients receiving hemodialysis.
format Online
Article
Text
id pubmed-8147568
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Japan Atherosclerosis Society
record_format MEDLINE/PubMed
spelling pubmed-81475682021-05-28 Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study Tanaka, Shigeru Nakano, Toshiaki Hiyamuta, Hiroto Taniguchi, Masatomo Tokumoto, Masanori Masutani, Kosuke Ooboshi, Hiroaki Tsuruya, Kazuhiko Kitazono, Takanari J Atheroscler Thromb Original Article Aim: Multivascular disease, indicating concurrent arteriosclerotic lesions in a number of different vascular beds, is an independent risk factor for recurrent ischemic events in the general population. However, the impact of multivascular disease on the risk of developing cardiovascular disease has not been fully evaluated in patients receiving hemodialysis. Methods: A total of 3,504 hemodialysis patients were prospectively followed for 10 years. In this study, multivascular disease was defined as the coexistence of coronary artery disease and stroke. We examined the relationship between multivascular disease and the occurrence of composite cardiovascular endpoint, consisting of cardiovascular death, nonfatal coronary artery disease, nonfatal stroke, and peripheral artery disease. Results: The proportion of participants with multivascular disease was 5.7% (n = 200) at baseline. During follow-up (median, 106.6 months; interquartile range, 50.1–121.8 months), 1,311 patients experienced the composite endpoint, which was defined as at least one of the following: cardiovascular death (n = 620), nonfatal coronary artery disease (n = 318), nonfatal stroke (n = 340), and peripheral artery disease (n = 257). Compared with the group with no history of cardiovascular disease, the risk of experiencing the composite endpoint increased significantly with higher numbers of injured vascular beds in patients with single vascular disease (hazard ratio, 1.68; 95% confidence interval, 1.49–1.89) and in those with multivascular disease (hazard ratio, 2.11; 95% confidence interval, 1.71–2.60). In a multivariable analysis, multivascular disease was an independent predictor of cardiovascular events, in addition to diabetes, aging, and hypertension. Conclusions: This study clearly demonstrated that multivascular disease was a powerful predictor for cardiovascular mortality and morbidity in patients receiving hemodialysis. Japan Atherosclerosis Society 2021-04-01 /pmc/articles/PMC8147568/ /pubmed/32684556 http://dx.doi.org/10.5551/jat.54098 Text en 2021 Japan Atherosclerosis Society https://creativecommons.org/licenses/by-nc-sa/3.0/This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/ (https://creativecommons.org/licenses/by-nc-sa/3.0/)
spellingShingle Original Article
Tanaka, Shigeru
Nakano, Toshiaki
Hiyamuta, Hiroto
Taniguchi, Masatomo
Tokumoto, Masanori
Masutani, Kosuke
Ooboshi, Hiroaki
Tsuruya, Kazuhiko
Kitazono, Takanari
Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
title Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
title_full Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
title_fullStr Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
title_full_unstemmed Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
title_short Impact of Multivascular Disease on Cardiovascular Mortality and Morbidity in Patients Receiving Hemodialysis: Ten-Year Outcomes of the Q-Cohort Study
title_sort impact of multivascular disease on cardiovascular mortality and morbidity in patients receiving hemodialysis: ten-year outcomes of the q-cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147568/
https://www.ncbi.nlm.nih.gov/pubmed/32684556
http://dx.doi.org/10.5551/jat.54098
work_keys_str_mv AT tanakashigeru impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT nakanotoshiaki impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT hiyamutahiroto impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT taniguchimasatomo impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT tokumotomasanori impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT masutanikosuke impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT ooboshihiroaki impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT tsuruyakazuhiko impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy
AT kitazonotakanari impactofmultivasculardiseaseoncardiovascularmortalityandmorbidityinpatientsreceivinghemodialysistenyearoutcomesoftheqcohortstudy